Sara Karlovitch


Rates of Thrombosis in Patients Treated With Hydroxyurea Fairly Stable Over Time, Review Finds

February 07, 2020

Mortality and myelofibrosis varied depending on follow-up duration in this review of patients with polycythemia vera treated with hydroxyurea, and incidences of thrombosis and acute myeloid leukemia (AML) were stable over time.

Evidence Shows Genetic, Epigenetic Factors May Be Responsible for Migraine Transformation

January 18, 2020

Individuals’ susceptibility to genetic and epigenetic factors may be responsible for the transformation of episodic migraine to chronic migraine in some patients, according to a new review published in The Journal of Headache and Pain.

Cancer Immunotherapy Likely Safe, Effective for Those With HIV, Other Infections, Study Suggests

January 12, 2020

Although the researchers state that more studies are needed to validate their findings, they found that patients who also had HIV, HBV, or HCV who were being treated with ICI therapy had similar rates of efficacy and toxicity to patients without chronic viral infections.

Researchers Suggest Reduction, Optimization of Antibiotic Prescriptions to Limit Drug Resistance Risk for Patients With Mild to Moderate COPD

January 11, 2020

For those with mild to moderate chronic obstructive pulmonary disease (COPD), researchers suggest that antibiotic stewardship focus on reducing and optimizing antibiotic use in patients with severe COPD who have a significant risk of drug resistance, according to study findings.